Johnson Pharmacare Limited announced the appointment of a new Additional Executive Director following a board meeting held on February 09, 2026. The pharmaceutical company's board approved the appointment in compliance with regulatory requirements under SEBI listing obligations.

Board Meeting Details

The board meeting was conducted on Monday, February 09, 2026, with specific timing and agenda focused on directorial appointments.

New Director Appointment

The board approved the appointment of Mr. Umesh Kumar as Additional Executive Director with immediate effect. The appointment was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance

As part of the appointment process, Mr. Umesh Kumar submitted a declaration of non-debarment as required under SEBI regulations. The declaration confirms his eligibility to hold the directorial position and states that he is not related to existing Directors or Key Managerial Personnel of the Company.

Key compliance confirmations include:

• Not debarred from accessing the Capital Market
• No orders passed by SEBI or other authorities debarring him from holding director positions
• Full compliance with SEBI (LODR) 2015 requirements
• Declaration signed on February 09, 2026, from Haryana

Company Information

Johnson Pharmacare Limited operates from its registered office located at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company trades under scrip code 532154 on BSE Limited with ISIN INE560F01022.

The appointment was signed and approved by Rajender Parsad, Additional Director (DIN: 10871533), on behalf of the Board of Directors of Johnson Pharmacare Limited. The company's CIN is L51100GJ1994PLC022388.

Johnson pharmacare Limited has announced a significant board-level change following a meeting held on January 31, 2026. The company's Board of Directors convened from 6:10 p.m. to 6:40 p.m. to address the resignation of a key executive director.

Director Resignation Details

The board approved the resignation of Mr. Umesh Kumar (DIN: 07015921) from his position as Additional & Executive Director, effective January 31, 2026. The resignation was submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Confirmation

Johnson Pharmacare Limited received formal confirmation from Mr. Umesh Kumar stating that there are no other material reasons for his resignation beyond those provided in his resignation letter. In his formal resignation communication, Mr. Kumar cited personal and unavoidable reasons as the basis for stepping down from his role.

The resignation letter addressed to the Board of Directors specifically mentioned his departure from the Board of Directors and respective Board Committees where he served as a member. Mr. Kumar requested the board to complete all necessary formalities under the Companies Act, 2013, and LODR regulations.

Additional Directorships

According to the company's disclosure, Mr. Umesh Kumar holds directorship in one other listed entity:

• Space Incubatrics Technologies Limited - serving in a professional capacity

Regulatory Compliance

The announcement was made in compliance with SEBI regulations, with the disclosure submitted to BSE Limited under scrip code 532154. The company's registered office is located in Ahmedabad, Gujarat, while its corporate office operates from New Delhi.

Rajender Parsad, Additional Director (DIN: 10871533), signed the disclosure on behalf of the Board of Directors, ensuring proper documentation and regulatory compliance for the directorial change.